Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report

Off-label drug use refers to drug use beyond the specifications authorized for marketing [J Med Case Rep. 2014 Dec;8(1):303]. Eltrombopag is a thrombopoietin receptor agonist that has been used in treating thrombocytopenia due to chronic liver disease (CLD) as an off-label medication. Treatment of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Sabah E., Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443640/
https://www.ncbi.nlm.nih.gov/pubmed/32884532
http://dx.doi.org/10.1159/000507987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443640/
https://www.ncbi.nlm.nih.gov/pubmed/32884532
http://dx.doi.org/10.1159/000507987

Ejemplares similares